Healthy Subjects
Showing 51 - 75 of >10,000
Healthy Subjects Trial in Austin (Vorasidenib 40 mg Oral Tablet, Ciprofloxacin 500 mg Oral Tablet, Vorasidenib 10 mg Oral
Recruiting
- Healthy Subjects
- Vorasidenib 40 mg Oral Tablet
- +2 more
-
Austin, TexasPPD Development
May 3, 2023
T2DM (Type 2 Diabetes) Trial in Beijing (HSK7653, Placebo)
Completed
- T2DM (Type 2 Diabetes Mellitus)
- HSK7653
- Placebo
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Aug 1, 2023
Healthy Subject Trial in Seoul (Neomazine Tab. 100mg, Myungin Chlorpromazine HCl Tab. 100mg)
Completed
- Healthy Subject
- Neomazine Tab. 100mg
- Myungin Chlorpromazine HCl Tab. 100mg
-
Seoul, Korea, Republic ofWhan In Pharm.
Nov 23, 2023
Diabetes Trial in Chengdu (INS062 injection, Insulin Aspart, HR20014 injection)
Recruiting
- Diabetes
- INS062 injection
- +3 more
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Feb 8, 2023
Dynamic Foot Print in Chronic Ankle Instability Versus Healthy
Not yet recruiting
- Ankle Sprains
- (no location specified)
Jan 27, 2023
Alzheimer Trial in Auburn (Extra virgin olive oil)
Not yet recruiting
- Alzheimer Disease
- Extra virgin olive oil
-
Auburn, AlabamaAuburn University
Jul 1, 2023
Diet, Healthy Trial in Surabaya (Konjac Grain)
Not yet recruiting
- Diet, Healthy
- Konjac Grain
-
Surabaya, Jawa Timur, IndonesiaUniversitas Katolik Widya Mandala Surabaya
May 8, 2023
Characteristics of Ephemeral® Tattoo Ink in Healthy Subjects
Completed
- Tattoo; Pigmentation
- Vibrancy Assessment
-
Milford, ConnecticutBrennal Pierre
May 25, 2023
Healthy Trial (CM326)
Not yet recruiting
- Healthy
- CM326
- (no location specified)
Jan 27, 2023
Kidney Transplantation Trial (SHR-2106 injection or )
Not yet recruiting
- Kidney Transplantation
- SHR-2106 injection or placebo
- (no location specified)
Jul 9, 2023
Healthy Volunteers Trial in Qingdao (SIM0278 Injection/Placebo)
Recruiting
- Healthy Volunteers
- SIM0278 Injection/Placebo
-
Qingdao, China, Shandong, ChinaAffiliated Hospital of Qingdao University
Aug 31, 2023
Prevention of Graft Rejection After Organ Transplantation Trial in Beijing (SHR-3032, SHR-3032 Placebo)
Not yet recruiting
- Prevention of Graft Rejection After Organ Transplantation
- SHR-3032
- SHR-3032 Placebo
-
Beijing, Beijing, ChinaPeking University Third Hospital
Oct 13, 2023
Primary Immune Thrombocytopenia Trial in Beijing (STSA-1301 subcutaneous injection, Placebo)
Recruiting
- Primary Immune Thrombocytopenia
- STSA-1301 subcutaneous injection
- Placebo
-
Beijing, Chaoyang District, ChinaBeijing Ditan Hospital,Capital Medical University
Nov 28, 2023
Healthy Trial in Zürich (Dimethyltryptamin (DMT) & Harmine)
Not yet recruiting
- Healthy
- Dimethyltryptamin (DMT) & Harmine
-
Zürich, ZH, SwitzerlandUniversity Hospital of Psychiatry Zurich
Apr 13, 2023
Healthy Subjects Trial in Glendale (Nintedanib, AZD5055)
Not yet recruiting
- Healthy Subjects
-
Glendale, United KingdomResearch Site
Dec 1, 2022
Healthy Subjects Trial in Lausanne (ACT-132577, Placebo)
Completed
- Healthy Subjects
- Aprocitentan
- Placebo
-
Lausanne, SwitzerlandInvestigator Site Lausanne
Nov 22, 2022
Food Effect in Healthy Participants Trial in Beijing (JAB-21822)
Not yet recruiting
- Food Effect in Healthy Participants
-
Beijing, Beijing, ChinaBeijing GoBroad Boren Hospital
May 16, 2023
Diabetes Trial (INS062 injection?INS068 injection?HR20014 injection)
Not yet recruiting
- Diabetes
- INS062 injection、INS068 injection、HR20014 injection
- (no location specified)
May 24, 2023
Stroke, Healthy Trial (Upper limb pointing movements in 3 experimental conditions)
Not yet recruiting
- Stroke
- Healthy
- Upper limb pointing movements in 3 experimental conditions
- (no location specified)
Oct 30, 2023
Psoriasis Trial in Shanghai (HS-10374 tablets, HS-10374-matched tablets)
Completed
- Psoriasis
- HS-10374 tablets
- HS-10374-matched placebo tablets
-
Shanghai, Shanghai, ChinaHuashan Hospital Affiliated to Fudan University
Sep 5, 2023
Breast Cancer, Nonsmall Cell Lung Cancer Trial in Beijing ([14C]GB491)
Completed
- Breast Cancer
- Nonsmall Cell Lung Cancer
-
Beijing, Beijing, ChinaBeijing GoBroad Boren Hospital
May 5, 2023
Healthy Trial in Miami (Relacorilant under fasted conditions, Relacorilant after a high-fat meal, Relacorilant after a low-fat
Completed
- Healthy
- Relacorilant under fasted conditions
- +2 more
-
Miami, FloridainVentiv Health Clinical Research Services LLC
Oct 17, 2023
Influenza, Human Trial in Shanghai (ZX-7101A, Placebo)
Not yet recruiting
- Influenza, Human
- ZX-7101A
- Placebo
-
Shanghai, Shanghai, ChinaHuashan Hospital affiliated to Fudan University
Jul 20, 2023
Healthy Subjects Trial in Nanjing ([14C] IBI351)
Not yet recruiting
- Healthy Subjects
- [14C] IBI351
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Nov 15, 2022